What does Visby Medical do?
Visby Medical develops at-home polymerase chain reaction (PCR) diagnostics that deliver laboratory-accurate results in under 30 minutes. The company offers single-use, instrument-free tests for sexually transmitted infections and respiratory infections, making crucial testing accessible both in clinical settings and directly to consumers at home.
How much did they raise?
The company raised approximately $55M in its latest round, led by Catalio Capital Management with participation from ND Capital, Cedars Sinai Medical Center, Blue Water Life Science Advisors, Pitango Ventures, and John Doerr. This round brought Visby Medical's total funding to $65M.
What are their plans for the money?
With the new funds, Visby Medical plans to accelerate the launch and distribution of its FDA-authorized at-home women's sexual health test. The move is expected to enhance access to rapid and accurate diagnostics, potentially transforming patient care in the realm of infectious diseases.
What have they achieved so far?
Visby Medical has already achieved significant milestones, including FDA clearance for its at-home tests for sexually transmitted infections and respiratory infections, underscoring its progress in advancing accessible diagnostic solutions.